Raltegravir central nervous system tolerability in clinical practice-Reference-Cited by-同舟云学术

Raltegravir central nervous system tolerability in clinical practice

Published:2012-11-28 Issue:18 Volume:26 Page:2412-2415
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Madeddu Giordano,Menzaghi Barbara,Ricci Elena,Carenzi Laura,Martinelli Canio,di Biagio Antonio,Parruti Giustino,Orofino Giancarlo,Mura Maria S.,Bonfanti Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.;Lennox;Lancet,2009

2. Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.;Markowitz;J Acquir Immune Defic Syndr,2009

3. Long-term efficacy and safety of raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase III trials.;Steigbigel;Clin Infect Dis,2010

4. Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a phase II study.;Gatell;J Acquir Immune Defic Syndr,2010

5. The hunt for HIV-1 integrase inhibitors.;Lataillade;AIDS Patient Care STDS,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study;Viruses;2023-03-10

2. Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer;AIDS Research and Therapy;2022-09-23

3. Class-Based Antiretroviral Exposure and Cognition Among Women Living with HIV;AIDS Research and Human Retroviruses;2022-07-01

4. Reversibility of Central Nervous System Adverse Events in Course of Art;Viruses;2022-05-11

5. Integrase Inhibitors are Associated with Neuropsychiatric Symptoms in Women with HIV;Journal of Neuroimmune Pharmacology;2022-02-17